Head-to-head comparison
GOAL.MD vs Shed
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
GOAL.MD is a St. Louis-based telehealth platform offering compounded semaglutide alongside brand-name bridges to Ozempic, Wegovy, and Zepbound. Its standout is a manual-renewal model — no auto-billing
$179/mo sema · From $249/mo (lowest dose rung) tirz · Verified July 2026
Marked down on: No named compounding pharmacy partner
Desk Score
Widest formulation spread in the ranking — injection, liquid drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.
$199/mo sema · $299/mo tirz · Verified August 2026
Marked down on: The advertised "as low as $239" tirzepatide rate needs a twelve-month commitment — month-to-month is $299
Shed takes this head-to-head with the higher Desk Score, 88/100 (B+) against 80/100 (B−) for GOAL.MD. GOAL.MD still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
GOAL.MD
80/100
B−
Shed
88/100
B+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | GOAL.MD | Shed |
|---|---|---|
| Semaglutide | $179/mo$179/mo | $199/mo$199/mo month-to-month ($179/mo on the 6-month plan, $159/mo on the 12-month plan — both carry a minimum term whose shipped cycles are non-refundable) |
| Tirzepatide | From $249/molowest dose rung$249/mo (starting dose, compounded) | $299/mo$299/mo month-to-month ($269/mo on the 6-month plan, $239/mo on the 12-month plan — both carry a minimum term whose shipped cycles are non-refundable) |
| Coverage | All 50 states | All 50 states (no state list is published on the site) |
| Brand-name | Yes | Yes |
| Oral option | Yes | Yes |
| Best for | Manual-renewal billing with dose-tiered brand-name pricing transparency. | People who want a needle-free route or a brand-name option without leaving one provider. |
| Desk Score | 80/100B− | 88/100B+ |
The verdict
Desk pick — ShedShed takes this head-to-head with the higher Desk Score, 88/100 (B+) against 80/100 (B−) for GOAL.MD. GOAL.MD still holds its ground where its strengths line up with yours.
Choose GOAL.MD if…
Manual-renewal billing with dose-tiered brand-name pricing transparency.
$179/mo sema · From $249/mo (lowest dose rung) tirz · All 50 states
Choose Shed if…
People who want a needle-free route or a brand-name option without leaving one provider.
$199/mo sema · $299/mo tirz · All 50 states (no state list is published on the site)
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: GOAL.MD · Shed.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs GOAL.MD
- CoreAge Rx vs Shed
- GOAL.MD vs Sesame Care
- Shed vs Vaylen
- GOAL.MD vs Vaylen
- Curex vs Shed
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.